2009-11-10 00:25:05 -
InterMune, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com
www.companiesandmarkets.com/Summary-Company-Profile/intermune,-i ..
InterMune, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
InterMune, Inc. (InterMune) is a biopharmaceutical company engaged in the development and marketing of innovative therapies in areas of pulmonology and hepatology. The company is developing a pipeline of pulmonology and hepatology products for treating idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. Its pulmonology products consist of a Phase 3 program, CAPACITY for treating patients with IPF and a research program on small molecules for pulmonary diseases. Its hepatology product is the HCV protease inhibitor compound ITMN-191 and a research program which evaluates new targets in hepatology. The company is headquartered in California, United States
The InterMune, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is
an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
